My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Public release date: 28-Apr-2008 Alendronate, a medication used to prevent fractures in women with osteoporosis, may be associated with an increased risk of atrial fibrillation, a type of abnormal heart…
Public release date: 29-Apr-2008 Contaminated heparin, a blood thinner used in dialysis and other treatments, has been connected to 81 deaths and 785 severe allergic reactions, said Rep. Bart…
Public release date: 29-Apr-2008 CHICAGO | Experimental blood substitutes raised the risk of heart attack and death, yet U.S. regulators allowed human testing to continue despite warning signs, a scathing…
Public release date: 2-Apr-2008 STANFORD, Calif. - Proposed guidelines from the U.S. Food and Drug Administration would allow companies to market more drugs for unapproved uses and are a step…
Public release date: 4-Apr-2008 Unless a researcher has stock ownership in a company whose drug is being tested, telling potential research volunteers about an investigator’s financial interests is unlikely to…
Public release date: 24-Mar-2008 Contact: Maja Fiket fi.maja@googlemail.com 773-702-6241 University of Chicago Medical Center Following free drug sample receipt, patients who receive these samples have significantly higher out-of-pocket prescription costs…
Public release date: 24-Mar-2008 Contact: Jann Ingmire 312-464-2499 JAMA and Archives Journals In an editorial published early online today, JAMA Editor-in-Chief Catherine D. DeAngelis, M.D., M.P.H., and JAMA Editorial Counsel…
Public release date: 24-Mar-2008 Contact: Suzanne Wu suzanne.wu@usc.edu 213-740-0252 University of Southern California In the current issue of The RAND Journal of Economics, USC researchers provide a challenge to the…
Public release date: 25-Mar-2008 Contact: Liz Savage jncimedia@oxfordjournals.org 301-841-1287 Journal of the National Cancer Institute Hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence in breast cancer…
Public release date: 25-Mar-2008 COLUMBUS, Ohio - A new study reviewing 75 group-randomized cancer trials over a five-year stretch shows that fewer than half of those studies used appropriate…
Public release date: 26-Mar-2008 Contact: Amy Lavoie amy_lavoie@harvard.edu 617-496-9982 Harvard University Fast-tracked medications more likely to face later regulatory action to remedy safety concerns CAMBRIDGE, Mass. – Many medications are…
Public release date: 26-Mar-2008 Contact: Paul Francuch francuch@uic.edu 312-996-3457 University of Illinois at Chicago Mercury is a large component of dental fillings, but it is not believed to pose immediate…
Public Release: 31-Mar-2008Are blood thinners post-op killers? Current US guidelines for the prescription of potent anticoagulants by surgeons who perform joint replacement operations could be doing patients more harm than…
Public Release: 31-Mar-2008 Congress: Vytorin Makers Held Bad News TRENTON, N.J. (AP) -- A congressional committee, investigating whether the makers of cholesterol drug Vytorin withheld data that would hurt…
Public release date: 17-Mar-2008 The mounting U.S. drug price crisis can be contained and eventually reversed by separating drug discovery from drug marketing and by establishing a non-profit company to…
Public release date: 18-Mar-2008 Only two per cent of paediatric drug trials reported using independent safety monitoring committees that can help lead to the early detection of adverse drug…
Public release date: 7-Feb-2008 CHICAGO -- A new study by researchers at Northwestern University's Feinberg School of Medicine may change current thinking about how best to treat patients in respiratory…
Public release date: 11-Feb-2008 Study finds evidence of fake malaria drugs being manufactured in China A unique collaborative study between scientists, public health workers and police has led to…
Public release date: 18-Feb-2008 A sense of hopefulness does not improve as quickly as other symptoms ANN ARBOR, Mich. — People taking medication for depression typically see a lot…
Public release date: 18-Feb-2008 WASHINGTON - GlaxoSmithKline Plc's rotavirus vaccine is associated with increased pneumonia-related deaths and other adverse reactions, U.S. regulatory staff said in documents posted on Friday.…
You must be logged in to post a comment.